S&P 500   5,076.25 (-0.25%)
DOW   39,082.09 (-0.13%)
QQQ   438.02 (+0.28%)
AAPL   181.28 (-0.68%)
MSFT   409.22 (-0.27%)
META   484.60 (+0.12%)
GOOGL   138.36 (-3.89%)
AMZN   174.81 (-0.10%)
TSLA   200.29 (+4.33%)
NVDA   801.56 (+1.70%)
NIO   5.60 (+3.70%)
AMD   176.75 (+0.13%)
BABA   76.17 (+0.28%)
T   16.59 (-1.25%)
F   12.05 (-0.74%)
MU   90.74 (+5.51%)
CGC   3.49 (+3.87%)
GE   154.76 (+0.93%)
DIS   108.08 (+0.32%)
AMC   4.60 (+3.60%)
PFE   27.12 (-2.31%)
PYPL   59.51 (+0.59%)
XOM   104.71 (+0.84%)
S&P 500   5,076.25 (-0.25%)
DOW   39,082.09 (-0.13%)
QQQ   438.02 (+0.28%)
AAPL   181.28 (-0.68%)
MSFT   409.22 (-0.27%)
META   484.60 (+0.12%)
GOOGL   138.36 (-3.89%)
AMZN   174.81 (-0.10%)
TSLA   200.29 (+4.33%)
NVDA   801.56 (+1.70%)
NIO   5.60 (+3.70%)
AMD   176.75 (+0.13%)
BABA   76.17 (+0.28%)
T   16.59 (-1.25%)
F   12.05 (-0.74%)
MU   90.74 (+5.51%)
CGC   3.49 (+3.87%)
GE   154.76 (+0.93%)
DIS   108.08 (+0.32%)
AMC   4.60 (+3.60%)
PFE   27.12 (-2.31%)
PYPL   59.51 (+0.59%)
XOM   104.71 (+0.84%)
S&P 500   5,076.25 (-0.25%)
DOW   39,082.09 (-0.13%)
QQQ   438.02 (+0.28%)
AAPL   181.28 (-0.68%)
MSFT   409.22 (-0.27%)
META   484.60 (+0.12%)
GOOGL   138.36 (-3.89%)
AMZN   174.81 (-0.10%)
TSLA   200.29 (+4.33%)
NVDA   801.56 (+1.70%)
NIO   5.60 (+3.70%)
AMD   176.75 (+0.13%)
BABA   76.17 (+0.28%)
T   16.59 (-1.25%)
F   12.05 (-0.74%)
MU   90.74 (+5.51%)
CGC   3.49 (+3.87%)
GE   154.76 (+0.93%)
DIS   108.08 (+0.32%)
AMC   4.60 (+3.60%)
PFE   27.12 (-2.31%)
PYPL   59.51 (+0.59%)
XOM   104.71 (+0.84%)
S&P 500   5,076.25 (-0.25%)
DOW   39,082.09 (-0.13%)
QQQ   438.02 (+0.28%)
AAPL   181.28 (-0.68%)
MSFT   409.22 (-0.27%)
META   484.60 (+0.12%)
GOOGL   138.36 (-3.89%)
AMZN   174.81 (-0.10%)
TSLA   200.29 (+4.33%)
NVDA   801.56 (+1.70%)
NIO   5.60 (+3.70%)
AMD   176.75 (+0.13%)
BABA   76.17 (+0.28%)
T   16.59 (-1.25%)
F   12.05 (-0.74%)
MU   90.74 (+5.51%)
CGC   3.49 (+3.87%)
GE   154.76 (+0.93%)
DIS   108.08 (+0.32%)
AMC   4.60 (+3.60%)
PFE   27.12 (-2.31%)
PYPL   59.51 (+0.59%)
XOM   104.71 (+0.84%)
NASDAQ:KTOV

Purple Biotech (KTOV) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.68
$0.74
50-Day Range
$3.81
$4.94
52-Week Range
$2.20
$14.40
Volume
58,983 shs
Average Volume
1.18 million shs
Market Capitalization
$10.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

KTOV stock logo

About Purple Biotech Stock (NASDAQ:KTOV)

Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension in the United States, as well as in China and South Korea. Its oncology pipeline includes NT-219, a small molecule that is advancing as a monotherapy treatment of advanced solid tumors and in combination with cetuximab for the treatment of recurrent or metastatic squamous cell carcinoma of head and neck cancer in a planned phase 1/2 study; and CM-24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD1 checkpoint inhibitors for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech Ltd. is headquartered in Tel Aviv, Israel.


KTOV Stock News Headlines

Purple Biotech: Q3 Earnings Insights
Purple Biotech GAAP EPS of -$0.23
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
PPBT Purple Biotech Ltd.
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Purple Carrot Discount Codes
Purple Promo Codes 2023
Purple Biotech (PPBT) Receives a Buy from H.C. Wainwright
See More Headlines
Receive KTOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:KTOV
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1 million
Book Value
$5.56 per share

Miscellaneous

Free Float
N/A
Market Cap
$10.93 million
Optionable
Not Optionable
Beta
2.37
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Isaac Israel (Age 42)
    CEO & Director
    Comp: $564.48k
  • Mr. Gil Efron CPA (Age 54)
    Deputy CEO & CFO
    Comp: $356.91k
  • Mr. Avraham Shlomo Ben-Tzvi (Age 49)
    Group Chief Legal Officer, Gen. Counsel & Corp. Sec.
  • Mr. Simcha Rock CPA (Age 70)
    M.B.A., CPA, MBA, Strategic Advisor & Director
  • Dr. Bertrand C. Liang (Age 57)
    Chief Medical Officer
  • Dr. Michael Schickler (Age 62)
    Head of Clinical Operations














KTOV Stock Analysis - Frequently Asked Questions

When did Purple Biotech's stock split?

Shares of Purple Biotech reverse split on the morning of Saturday, August 22nd 2020. The 1-10 reverse split was announced on Friday, August 21st 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 21st 2020. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Purple Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Purple Biotech investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), T2 Biosystems (TTOO), Southwestern Energy (SWN), VBI Vaccines (VBIV), Onconova Therapeutics (ONTX), Advanced Micro Devices (AMD), Vaxart (VXRT), Amarin (AMRN) and Citius Pharmaceuticals (CTXR).

When did Purple Biotech IPO?

(KTOV) raised $13 million in an IPO on Friday, November 20th 2015. The company issued 3,200,000 shares at a price of $4.13 per share. Rodman & Renshaw (a unit of H.C. Wainwright & Co.,) and Joseph Gunnar served as the underwriters for the IPO.

This page (NASDAQ:KTOV) was last updated on 2/26/2024 by MarketBeat.com Staff